Literature DB >> 27456865

TRPV1 receptor in the human trigeminal ganglion and spinal nucleus: immunohistochemical localization and comparison with the neuropeptides CGRP and SP.

Marina Quartu1, Maria Pina Serra1, Marianna Boi1, Laura Poddighe1, Cristina Picci1, Roberto Demontis2, Marina Del Fiacco1.   

Abstract

This work presents new data concerning the immunohistochemical occurrence of the transient receptor potential vanilloid type-1 (TRPV1) receptor in the human trigeminal ganglion (TG) and spinal nucleus of subjects at different ontogenetic stages, from prenatal life to postnatal old age. Comparisons are made with the sensory neuropeptides calcitonin gene-related peptide (CGRP) and substance P (SP). TRPV1-like immunoreactive (LI) material was detected by western blot in homogenates of TG and medulla oblongata of subjects at prenatal and adult stages of life. Immunohistochemistry showed that expression of the TRPV1 receptor is mostly restricted to the small- and medium-sized TG neurons and to the caudal subdivision of the spinal trigeminal nucleus (Sp5C). The extent of the TRPV1-LI TG neuronal subpopulation was greater in subjects at early perinatal age than at late perinatal age and in postnatal life. Centrally, the TRPV1 receptor localized to fibre tracts and punctate elements, which were mainly distributed in the spinal tract, lamina I and inner lamina II of the Sp5C, whereas stained cells were rare. The TRPV1 receptor colocalized partially with CGRP and SP in the TG, and was incompletely codistributed with both neuropeptides in the spinal tract and in the superficial laminae of the Sp5C. Substantial differences were noted with respect to the distribution of the TRPV1-LI structures described in the rat Sp5C and with respect to the temporal expression of the receptor during the development of the rat spinal dorsal horn. The distinctive localization of TRPV1-LI material supports the concept of the involvement of TRPV1 receptor in the functional activity of the protopathic compartment of the human trigeminal sensory system, i.e. the processing and neurotransmission of thermal and pain stimuli.
© 2016 Anatomical Society.

Entities:  

Keywords:  calcitonin gene-related peptide; human trigeminal system; immunohistochemistry; substance P; transient receptor potential vanilloid type-1 receptor; western blot

Mesh:

Substances:

Year:  2016        PMID: 27456865      PMCID: PMC5108161          DOI: 10.1111/joa.12529

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  77 in total

1.  Capsaicin jelly against migraine pain.

Authors:  C Cianchetti
Journal:  Int J Clin Pract       Date:  2010-03       Impact factor: 2.503

Review 2.  Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

Authors:  Gilbert Y Wong; Narender R Gavva
Journal:  Brain Res Rev       Date:  2008-12-25

3.  Vanilloid receptor VR1-positive afferents are distributed differently at different levels of the rat lumbar spinal cord.

Authors:  S J Hwang; J G Valtschanoff
Journal:  Neurosci Lett       Date:  2003-09-25       Impact factor: 3.046

Review 4.  Tackling pain at the source: new ideas about nociceptors.

Authors:  W D Snider; S B McMahon
Journal:  Neuron       Date:  1998-04       Impact factor: 17.173

5.  Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat.

Authors:  Juan Miguel Jimenez-Andrade; Christopher M Peters; Nicole A Mejia; Joseph R Ghilardi; Michael A Kuskowski; Patrick W Mantyh
Journal:  Neurosci Lett       Date:  2006-07-18       Impact factor: 3.046

6.  TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord.

Authors:  Yong Ho Kim; Seung Keun Back; Alexander J Davies; Heejin Jeong; Hyun Jung Jo; Geehoon Chung; Heung Sik Na; Yong Chul Bae; Sang Jeong Kim; Joong Soo Kim; Sung Jun Jung; Seog Bae Oh
Journal:  Neuron       Date:  2012-05-24       Impact factor: 17.173

7.  Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain.

Authors:  Yu Shin Kim; Yuxia Chu; Liang Han; Man Li; Zhe Li; Pamela Colleen LaVinka; Shuohao Sun; Zongxiang Tang; Kyoungsook Park; Michael J Caterina; Ke Ren; Ronald Dubner; Feng Wei; Xinzhong Dong
Journal:  Neuron       Date:  2014-01-23       Impact factor: 17.173

8.  Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score.

Authors:  Z Yilmaz; T Renton; Y Yiangou; J Zakrzewska; I P Chessell; C Bountra; P Anand
Journal:  J Clin Neurosci       Date:  2007-06-19       Impact factor: 1.961

Review 9.  TRPV1 splice variants: structure and function.

Authors:  Mark A Schumacher; Helge Eilers
Journal:  Front Biosci (Landmark Ed)       Date:  2010-06-01

Review 10.  TRPA1 and other TRP channels in migraine.

Authors:  Silvia Benemei; Francesco De Cesaris; Camilla Fusi; Eleonora Rossi; Chiara Lupi; Pierangelo Geppetti
Journal:  J Headache Pain       Date:  2013-08-13       Impact factor: 7.277

View more
  18 in total

1.  Prevention of Chronic Post-Thoracotomy Pain in Rats By Intrathecal Resolvin D1 and D2: Effectiveness of Perioperative and Delayed Drug Delivery.

Authors:  Jeffery Chi-Fei Wang; Gary R Strichartz
Journal:  J Pain       Date:  2017-01-04       Impact factor: 5.820

2.  TRPV1-Like Immunoreactivity in the Human Locus K, a Distinct Subregion of the Cuneate Nucleus.

Authors:  Marina Del Fiacco; Maria Pina Serra; Marianna Boi; Laura Poddighe; Roberto Demontis; Antonio Carai; Marina Quartu
Journal:  Cells       Date:  2018-07-08       Impact factor: 6.600

Review 3.  The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse.

Authors:  Willem Sebastiaan van Hoogstraten; Antoinette MaassenVanDenBrink
Journal:  J Headache Pain       Date:  2019-05-16       Impact factor: 7.277

4.  Capsaicin-enriched diet ameliorates autoimmune neuritis in rats.

Authors:  Jeremias Motte; Björn Ambrosius; Thomas Grüter; Hussein Bachir; Melissa Sgodzai; Xiomara Pedreiturria; Kalliopi Pitarokoili; Ralf Gold
Journal:  J Neuroinflammation       Date:  2018-04-24       Impact factor: 8.322

5.  Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells.

Authors:  Thomas Grüter; Alina Blusch; Jeremias Motte; Melissa Sgodzai; Hussein Bachir; Rafael Klimas; Björn Ambrosius; Ralf Gold; Gisa Ellrichmann; Kalliopi Pitarokoili
Journal:  J Neuroinflammation       Date:  2020-05-06       Impact factor: 8.322

6.  Orexin-A inhibits capsaicin-induced changes in cyclooxygenase-2 and brain-derived neurotrophic factor expression in trigeminal nucleus caudalis of rats.

Authors:  Razieh Kooshki; Mehdi Abbasnejad; Saeed Esmaeili Mahani; Maryam Raoof; Mohammad Mehdi Moeini Aghtaei; Shahriar Dabiri
Journal:  Korean J Pain       Date:  2018-07-02

7.  Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model.

Authors:  Chiara Demartini; Rosaria Greco; Anna Maria Zanaboni; Oscar Francesconi; Cristina Nativi; Cristina Tassorelli; Kristof Deseure
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

Review 8.  TRP Channels in the Focus of Trigeminal Nociceptor Sensitization Contributing to Primary Headaches.

Authors:  Mária Dux; Judit Rosta; Karl Messlinger
Journal:  Int J Mol Sci       Date:  2020-01-04       Impact factor: 5.923

Review 9.  Targeting Chemosensory Ion Channels in Peripheral Swallowing-Related Regions for the Management of Oropharyngeal Dysphagia.

Authors:  Mohammad Zakir Hossain; Hiroshi Ando; Shumpei Unno; Junichi Kitagawa
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

Review 10.  Implications of Transient Receptor Potential Cation Channels in Migraine Pathophysiology.

Authors:  Mamoru Shibata; Chunhua Tang
Journal:  Neurosci Bull       Date:  2020-09-01       Impact factor: 5.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.